Pioglitazone inhibits cancer cell growth through STAT3 inhibition and enhanced AIF expression via a PPARγ-independent pathway
出版年份 2017 全文链接
标题
Pioglitazone inhibits cancer cell growth through STAT3 inhibition and enhanced AIF expression via a PPARγ-independent pathway
作者
关键词
-
出版物
JOURNAL OF CELLULAR PHYSIOLOGY
Volume 233, Issue 4, Pages 3638-3647
出版商
Wiley
发表日期
2017-10-14
DOI
10.1002/jcp.26225
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Survivin: a unique target for tumor therapy
- (2016) Himani Garg et al. Cancer Cell International
- Functional activation of PPARγ in human upper aerodigestive cancer cell lines
- (2016) Simon K. Wright et al. MOLECULAR CARCINOGENESIS
- Prostaglandindsynthase is a potential novel therapeutic agent for the treatment of gastric carcinomas expressing PPARγ
- (2015) Tatsunari Fukuoka et al. INTERNATIONAL JOURNAL OF CANCER
- YM155, a survivin suppressant, triggers PARP-dependent cell death (parthanatos) and inhibits esophageal squamous-cell carcinoma xenografts in mice
- (2015) Nan Zhao et al. Oncotarget
- 15-Deoxy-Δ12,14-prostaglandin J2 inhibits IL-13 production in T cells via an NF-κB-dependent mechanism
- (2013) Marie-Christine Doyle et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Inhibition of the tumour necrosis factor-alpha autocrine loop enhances the sensitivity of multiple myeloma cells to anticancer drugs
- (2013) Masanobu Tsubaki et al. EUROPEAN JOURNAL OF CANCER
- Combinational effect of PPARγ agonist and RXR agonist on the growth of SGC7901 gastric carcinoma cells in vitro
- (2013) Ying Liu et al. TUMOR BIOLOGY
- Nitrogen-containing bisphosphonates induce apoptosis of hematopoietic tumor cells via inhibition of Ras signaling pathways and Bim-mediated activation of the intrinsic apoptotic pathway
- (2012) Masanobu Tsubaki et al. BIOCHEMICAL PHARMACOLOGY
- Cytotoxicity of 15-Deoxy-Δ12,14-prostaglandin J2 through PPARγ-independent Pathway and the Involvement of the JNK and Akt Pathway in Renal Cell Carcinoma
- (2012) Megumi Fujita et al. International Journal of Medical Sciences
- Expression of Peroxisome Proliferator Activated Receptor-Gamma (PPAR-γ) in Human Non-small Cell Lung Carcinoma: Correlation with Clinicopathological Parameters, Proliferation and Apoptosis Related Molecules and Patients’ Survival
- (2012) Costantinos Giaginis et al. PATHOLOGY & ONCOLOGY RESEARCH
- Troglitazone, a PPAR agonist, inhibits human prostate cancer cell growth through inactivation of NFκB via suppression of GSK-3β expression
- (2011) Jung Ok Ban et al. CANCER BIOLOGY & THERAPY
- A novel parthenin analog exhibits anti-cancer activity: Activation of apoptotic signaling events through robust NO formation in human leukemia HL-60 cells
- (2011) Ajay Kumar et al. CHEMICO-BIOLOGICAL INTERACTIONS
- The Antidiabetic Drug Ciglitazone Induces High Grade Bladder Cancer Cells Apoptosis through the Up-Regulation of TRAIL
- (2011) Marie-Laure Plissonnier et al. PLoS One
- AIF: Not Just an Apoptosis-Inducing Factor
- (2009) Nicholas Joza et al. Annals of the New York Academy of Sciences
- Rosiglitazone inhibits 4 nicotinic acetylcholine receptor expression in human lung carcinoma cells through peroxisome proliferator-activated receptor -independent signals
- (2009) X. Sun et al. MOLECULAR CANCER THERAPEUTICS
- PPARγ-independent antitumor effects of thiazolidinediones
- (2008) Shuo Wei et al. CANCER LETTERS
- SOCS 3 and PPAR-γ ligands inhibit the expression of IL-6 and TGF-β1 by regulating JAK2/STAT3 signaling in pancreas
- (2007) Ji Hoon Yu et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now